FindTrial
Sign In

The comparative study for Gd-eob-dtpa enhanced magnetic resonance imaging and enhanced CT in hepatic metastasis of pancreatic cancer

The comparative study for Gd-eob-dtpa enhanced magnetic resonance imaging and enhanced CT in hepatic metastasis of pancreatic cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060579
Enrollment
Unknown
Registered
2022-06-05
Start date
2022-06-10
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

Gold Standard:1. Pathological examination
2. Imaging follow-up.
Index test:1. A model to predict liver metastasis in pancreatic cancer

Sponsors

Affiliated Hospital of Guilin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with pancreatic cancer.

Exclusion criteria

Exclusion criteria: 1. There was no follow-up data or pathological diagnosis.

Design outcomes

Primary

MeasureTime frame
Intrahepatic metastases;Sensitivity;Specificity;Accuracy;—

Countries

China

Contacts

Public ContactJiangfa Li

Affiliated Hospital of Guilin Medical University

247546160@qq.com+86 0773-2824373

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026